의료기기 보안 시장 : 기기 유형별, 컴포넌트별, 접속성별, 보안 유형별, 도입 형태별, 최종 사용자별 시장 예측(2026-2032년)

The Medical Device Security Market is projected to grow by USD 22.54 billion at a CAGR of 12.69% by 2032.

Medical device security has become a board-level priority as connected medical devices, software as a medical device, remote patient monitoring platforms, and hospital IoT systems expand the clinical attack surface. The market is being shaped by stricter regulatory expectations, more sophisticated ransomware activity targeting healthcare delivery organizations, and the operational need to protect patient safety, protected health information, and clinical uptime.

Verified policy momentum is clear. The U.S. FDA requires cybersecurity information for many new device submissions under Section 524B of the FD&C Act, including secure development practices, vulnerability management, and software bill of materials expectations. Globally, frameworks from NIST, IMDRF, IEC 81001-5-1, and the EU Medical Device Regulation are reinforcing secure-by-design principles across the medical device lifecycle.

Transformative Shifts in the Medical Device Security Landscape

The medical device security landscape is shifting from perimeter-based protection to lifecycle cyber risk management. Healthcare providers and manufacturers are moving toward asset discovery, network segmentation, identity-based access, continuous monitoring, coordinated vulnerability disclosure, and postmarket surveillance that extends across the full operating life of connected devices.

Regulatory and procurement practices are also changing. Buyers increasingly expect evidence of threat modeling, secure software development, SBOM availability, patching processes, encryption, authentication controls, and incident response readiness. As legacy devices remain in service for years, security programs must balance patient safety, device availability, regulatory compliance, and modernization without disrupting clinical workflows.

Cumulative Impact of Artificial Intelligence on Medical Device Security

Artificial intelligence is creating cumulative impact across medical device security by improving asset classification, anomaly detection, vulnerability prioritization, malware analysis, fraud detection, and security operations workflows. AI-enabled monitoring can help identify abnormal device behavior, suspicious network traffic, and early indicators of compromise faster than manual review alone, which is critical in high-acuity clinical environments.

AI also introduces new risk considerations. Connected devices using machine learning may face model manipulation, data poisoning, adversarial inputs, privacy exposure, and validation challenges. Industry leaders are therefore aligning AI governance with FDA guidance on software, NIST AI Risk Management Framework principles, secure MLOps, auditability, and human oversight to ensure that AI strengthens resilience without creating unmanaged clinical or cybersecurity risk.

Key Regional Insights for Medical Device Security

Asia-Pacific is advancing rapidly as China, Japan, South Korea, India, Australia, and ASEAN markets scale digital health infrastructure, connected diagnostics, and hospital modernization. The region's demand is driven by growing healthcare digitization, larger patient populations, and stronger national cybersecurity policies, although maturity varies across procurement standards, hospital security capacity, and local implementation of medical device cybersecurity requirements.

North America remains a leading region due to FDA cybersecurity requirements, mature healthcare IT investment, high ransomware exposure, HIPAA-aligned security programs, and strong adoption of connected medical technologies. Europe is shaped by the EU MDR, NIS2 Directive, GDPR, ENISA guidance, and rising attention to cyber resilience, while Latin America is moving gradually as Brazil and Mexico expand digital care delivery, private hospital networks, and health data protection frameworks. The Middle East is investing in smart hospitals and national health transformation programs, particularly across the GCC, while Africa shows emerging demand tied to telemedicine, public health infrastructure modernization, donor-supported digital health initiatives, and the need for scalable, cost-effective security controls.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is becoming an important growth zone as Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines expand digital health programs and connected care delivery. Security adoption is strongest where national cybersecurity agencies, hospital accreditation programs, data protection rules, and cloud health platforms are more mature, with Singapore often setting a higher regional benchmark for healthcare cyber readiness.

The GCC is accelerating medical device security through smart hospital investments, public-sector healthcare transformation, and cloud-first strategies in Saudi Arabia, the UAE, Qatar, and neighboring markets. The European Union is one of the most regulation-driven environments, with MDR, GDPR, NIS2, and cyber resilience initiatives pushing manufacturers and providers toward documented security controls. BRICS countries combine scale and complexity, with China and India driving high-volume connected healthcare demand and Brazil and South Africa expanding digital health capacity. G7 and NATO members emphasize supply-chain assurance, vulnerability disclosure, critical infrastructure protection, ransomware resilience, and preparedness against state-linked cyber threats that can affect healthcare delivery and medical technology operations.

Key Country Insights for Medical Device Security Markets

The United States leads in regulatory clarity and commercial demand, supported by FDA cybersecurity expectations, HHS guidance, HIPAA security requirements, CISA healthcare advisories, and high healthcare cyber risk exposure. Canada emphasizes privacy, public healthcare resilience, and medical technology modernization, while Mexico and Brazil are expanding opportunities through private hospital growth, connected diagnostics, telehealth adoption, and stronger health data governance.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are strengthening hospital cybersecurity programs under national strategies, EU-aligned requirements, data protection obligations, and growing awareness of medical device vulnerabilities. Russia remains a distinct market shaped by local regulatory priorities, cybersecurity sovereignty policies, and import substitution pressures. In Asia-Pacific, China and India offer large-scale demand as healthcare digitization accelerates, while Japan, South Korea, and Australia show stronger security maturity through advanced hospital systems, medical technology manufacturing, national cybersecurity frameworks, and established digital health infrastructure.

Actionable Recommendations for Industry Leaders

Industry leaders should treat medical device security as an enterprise risk function rather than a narrow IT control. Manufacturers should implement secure-by-design engineering, threat modeling, SBOM governance, coordinated vulnerability disclosure, secure update mechanisms, cryptographic protections, and postmarket monitoring aligned with FDA, NIST, IMDRF, and IEC 81001-5-1 expectations.

Healthcare providers should build accurate device inventories, segment clinical networks, enforce identity and access controls, monitor device behavior, test incident response plans, and prioritize remediation based on clinical risk and patient safety impact. Both manufacturers and providers should strengthen third-party risk management, require cybersecurity evidence in procurement, and create cross-functional governance involving clinical engineering, IT security, compliance, legal, procurement, and patient safety teams.

Research Methodology

This executive summary is developed using a structured secondary-research methodology focused on verified, publicly available, and authoritative sources. The analysis reflects regulatory publications from the FDA, NIST, CISA, HHS, IMDRF, the European Commission, ENISA, and recognized standards bodies, alongside healthcare cybersecurity advisories, medical device guidance, and market-relevant policy developments.

The methodology emphasizes triangulation across regulatory signals, technology adoption patterns, regional healthcare digitization trends, cybersecurity threat intelligence, privacy requirements, and procurement expectations. Insights are synthesized to identify durable market drivers, risk factors, regional differences, and strategic implications for manufacturers, healthcare providers, investors, and cybersecurity vendors serving the medical device ecosystem.

Conclusion

Medical device security is entering a more disciplined, regulated, and intelligence-driven phase. The convergence of connected care, AI-enabled medical technologies, stricter cybersecurity requirements, and persistent healthcare cyber threats is raising expectations for security across product design, deployment, operations, and postmarket support.

Organizations that invest in secure-by-design devices, continuous monitoring, AI-assisted risk management, transparent software supply chains, and coordinated vulnerability response will be better positioned to protect patient safety, maintain clinical continuity, and meet evolving global compliance requirements. Medical device security is no longer optional; it is a foundational requirement for trusted digital healthcare.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Medical Device Security Market, by Device Type

• 7.1. Implantable Medical Devices
  • 7.1.1. Cardiac Implants
  • 7.1.2. Neurostimulators
  • 7.1.3. Cochlear Implants
• 7.2. Wearable Medical Devices
• 7.3. Stationary Medical Devices
  • 7.3.1. Imaging Systems
  • 7.3.2. Patient Monitoring Systems
  • 7.3.3. Infusion Pumps
  • 7.3.4. Ventilators
• 7.4. Diagnostic Equipment
  • 7.4.1. In Vitro Diagnostic Devices
  • 7.4.2. Point of Care Devices
• 7.5. Therapeutic Devices

8. Medical Device Security Market, by Component

• 8.1. Hardware
  • 8.1.1. Firewall
  • 8.1.2. Intrusion Detection System
  • 8.1.3. Secure Gateway
• 8.2. Services
  • 8.2.1. Consulting Services
  • 8.2.2. Integration & Deployment Services
  • 8.2.3. Training & Support Services
• 8.3. Software

9. Medical Device Security Market, by Connectivity

• 9.1. Wired
• 9.2. Wireless

10. Medical Device Security Market, by Security Type

• 10.1. Device Security
  • 10.1.1. Embedded Device Security
  • 10.1.2. Firmware Security
  • 10.1.3. Operating System Security
• 10.2. Network Security
• 10.3. Data Security
  • 10.3.1. Data Encryption
  • 10.3.2. Data Loss Prevention
  • 10.3.3. Data Masking
• 10.4. Endpoint Security

11. Medical Device Security Market, by Deployment Mode

• 11.1. Cloud
• 11.2. Hybrid
• 11.3. On Premises

12. Medical Device Security Market, by End User

• 12.1. Ambulatory Surgical Centers
• 12.2. Clinics
• 12.3. Diagnostic Laboratories
• 12.4. Home Healthcare
• 12.5. Hospitals

13. Medical Device Security Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Medical Device Security Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Medical Device Security Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Blue Goat Cyber LLC
• 17.2. Broadcom Inc.
• 17.3. Check Point Software Technologies Ltd.
• 17.4. Cisco Systems Inc.
• 17.5. Claroty Ltd.
• 17.6. ClearDATA Networks Inc.
• 17.7. Cybeats Technologies Corp.
• 17.8. CyberMDX Technologies Ltd.
• 17.9. Cynerio Ltd.
• 17.10. DXC Technology Company
• 17.11. Forescout Technologies Inc.
• 17.12. Fortinet Inc.
• 17.13. GE HealthCare Technologies Inc.
• 17.14. Greenlight Guru Inc.
• 17.15. Imperva Inc.
• 17.16. International Business Machines Corporation
• 17.17. McAfee Corp.
• 17.18. MedCrypt Inc.
• 17.19. Medtronic plc
• 17.20. Ordr Inc.
• 17.21. Palo Alto Networks Inc.
• 17.22. Philips N.V.
• 17.23. Remedio Ltd.
• 17.24. Siemens Healthineers AG
• 17.25. Sophos Ltd.
• 17.26. Stryker Corporation
• 17.27. Trend Micro Incorporated
• 17.28. Zingbox Inc.
• 17.29. Zscaler Inc.